Clinical Trials Logo

Filter by:
NCT ID: NCT03475368 Active, not recruiting - Nutrition Disorders Clinical Trials

Interactions Between Diet, Intestinal Microbiota and Metabolomics

Start date: April 1, 2018
Phase: N/A
Study type: Interventional

It is widely known that the quality of the diet is able to modify the expression of many bacterial genes populating the intestine of the host, as well as the type of bacteria themselves. This is also expressed with a more or less evident and troublesome after meals symptomatology that many patients complain to the health care staff. A good composition of the microbiota is crucial for the health of the individual, both at the intestinal level as well as at the systemic level because, depending on the type of food substrate available at the intestinal level, metabolites will be produced capable of positively or negatively affect the health of the individual. In fact, scientific evidence shows the existence of the causal link between the health of the microbiota and the genesis of inflammatory diseases not only intestinal, but also systemic, and even of cancer, obesity, metabolic syndrome and atherosclerosis. The recent diffusion of gene sequencing techniques has brought significant developments in the study of the human and bacterial genome, which allow to produce enormous quantities of sequences at a lower cost and at a higher speed than previous techniques. Therefore the clinical Nutrition Clinic of the IRCCS De Bellis in Castellana Grotte (BA) proposes to check if changes in the intestinal microbiota correlate, not only with anthropometric and clinical-laboratory parameters, but also with the typical symptoms of irritable bowel syndrome (IBS), a functional pathology very widespread with the advent of the modern era, in which, a diet rich in sugars and proteins of animal origin and poor in plant foods, is unfortunately common also in the areas of the Mediterranean basin.

NCT ID: NCT03478449 Active, not recruiting - Gastric Cancer Clinical Trials

The Criteria for Lymph Node Sorting for Pathological Examination in Gastric Cancer

Start date: April 1, 2018
Phase: N/A
Study type: Interventional

The aim of this study is intending to provide the optimal procedures of lymph node sorting for pathological examination after curative surgery for gastric cancer, which can discriminate the differences of the status of lymph node metastasis, pTNM classification and prognostic outcome of gastric cancer patients.

NCT ID: NCT03484754 Active, not recruiting - Major Depression Clinical Trials

Infiltrations of OnaBotulinum Toxin A in Resistant Depression: Comparison of Two Facial Injection Sites.

OnaDEP
Start date: April 1, 2018
Phase: N/A
Study type: Interventional

The aim of the study is to evaluate in adult subjects with resistant depression the effect of an injection of botulinum toxin in the corrugator and procerus muscles, in comparison to the infiltration of the crow's feet area, in addition to the current antidepressant treatment.

NCT ID: NCT03486418 Active, not recruiting - Clinical trials for Colorectal Neoplasms

European Serrated Adenoma Classification Score

ESCO
Start date: April 1, 2018
Phase:
Study type: Observational

The aim of the study is to develop a score system in order to differentiate adenomatous polyps, hyperplastic polyps and serrated adenomas on the basis of optical features. Endoscopic images of colorectal polyps will be collected from a prospectively managed database. Histopathological diagnoses are available for all polyps. Histopathological diagnoses serve as gold standard in this study. In the first phase of the study optical features of serrated adenomas are extracted from the database. Discriminators are then defined on the basis of the extracted features. In the second phase a test set of high quality pictures are provided to both novices and experts of colorectal endoscopy. Participants are asked to use the above named discriminators in order to rate pictures and to classify polyps into three classes (adenomatous polyps, hyperplastic polyps and serrated adenomas). In the third phase of the study accuracy of optical bases diagnoses is calculated by comparing optically derived diagnoses with histopathological diagnoses (gold standard).

NCT ID: NCT03495388 Active, not recruiting - Postoperative Pain Clinical Trials

PG and PK of Oxycodone to Personalize Post-op Pain Management Following Surgery in Children

Start date: April 1, 2018
Phase:
Study type: Observational

Each year, in the U.S. alone, >6 million children undergo painful surgery; up to 50% of them experience significant and serious side effects with opioids and inadequate pain relief. Though 60% of this inter-individual variability in responses results from genetic variations, there is an almost complete lack of understanding of how specific genetic variability affects pain and of the adverse effects of opioids, especially in children. In this project the investigators will focus on oxycodone, a standard and preferred post-surgical oral analgesic in children The purpose of this research is to study serious immediate and long-term clinical problems from both surgical pain and oxycodone use in children and adolescents to improve the safety and effectiveness of surgical pain relief. The long-term goals are to improve the safety and effectiveness of surgical pain relief with opioids (a class of drugs/pain relievers) and to minimize the societal burden of disabling Chronic Persistent Surgical Pain (CPSP, which is pain that persists even after the expected healing time from surgery) and Opioid Dependence (OD) by preoperative risk predictions and personalized care with the right dose of the right pain medication for each child. The overall objective is to determine the impact of risk factors on oxycodone's immediate and long-term negative postoperative outcomes and to personalize dosing in children undergoing outpatient and major inpatient surgery.

NCT ID: NCT03502382 Active, not recruiting - Clinical trials for Total Knee Replacement

Prediction of Leg Length Discrepancy After Unilateral Total Knee Replacement in Varus Deformity

Start date: April 1, 2018
Phase: N/A
Study type: Interventional

To What degree total knee replacement (TKA) affects leg length discrepancy in patients with varus deformity? Varus deformity, the most commonly encountered deformity in patients undergoing TKA is associated with limb alignment and varying degrees of contractures of medial soft tissue structures, laxity of the lateral soft tissue structures, flexion deformity and medial bone erosion at the knee joint .The challenges in performing TKA in a varus arthritic knee include restoration of limb alignment, balancing the medial and lateral soft tissue tension, equalizing flexion and extension gaps and restoring medial bone loss

NCT ID: NCT03503786 Active, not recruiting - Endometrial Cancer Clinical Trials

Carboplatin, Paclitaxel With or Without Avelumab in Advanced or Recurrent Endometrial Cancer

MITO END-3
Start date: April 1, 2018
Phase: Phase 2
Study type: Interventional

This study aims to evaluate the safety and activity of the Avelumab in combination with Carboplatin-Paclitaxel in advanced or recurrent endometrial cancer

NCT ID: NCT03509649 Active, not recruiting - Neck Pain Clinical Trials

Impact of Practitioner and Instructional Set on Subject Perceptions and Expectations of Cervical Spine Manipulation

Start date: April 1, 2018
Phase: N/A
Study type: Interventional

Determine effects of perceptions and expectations on experience of cervical spine manipulation

NCT ID: NCT03545750 Active, not recruiting - Critical Illness Clinical Trials

Renal Replacement Anticoagulant Management

RRAM
Start date: April 1, 2018
Phase:
Study type: Observational

Observational comparative effectiveness study of individual patient data using interrupted time series analysis techniques of linked data sources to establish clinical and health economic effects of moving from systemic heparin anticoagulation to regional citrate anticoagulation during continuous renal replacement therapy (CRRT) for patients treated on non-specialist Intensive Care Units (ICUs) in England and Wales.

NCT ID: NCT03573960 Active, not recruiting - Thyroid Neoplasms Clinical Trials

A Study to Evaluate the Safety and Efficacy of Lenvatinib in Participants With Refractory Differentiated Thyroid Cancer

Start date: April 1, 2018
Phase: Phase 4
Study type: Interventional

The purpose of this study is to evaluate the safety of lenvatinib in participants with recurrent, metastatic radio-iodine refractory differentiated thyroid cancer (DTC).